Slagle Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
77,839
+3,091
| +4% | +$74.9K | 0.76% | 54 |
|
|
2025
Q1 | $1.89M | Buy |
74,748
+1,120
| +2% | +$28.4K | 0.84% | 47 |
|
|
2024
Q4 | $1.95M | Buy |
73,628
+4,264
| +6% | +$113K | 0.88% | 45 |
|
|
2024
Q3 | $2.01M | Buy |
69,364
+5,141
| +8% | +$149K | 0.89% | 48 |
|
|
2024
Q2 | $1.8M | Buy |
64,223
+4,443
| +7% | +$124K | 0.92% | 47 |
|
|
2024
Q1 | $1.66M | Sell |
59,780
-45,168
| -43% | -$1.25M | 0.9% | 46 |
|
|
2023
Q4 | $1.51M | Buy |
104,948
+53,068
| +102% | +$764K | 0.87% | 49 |
|
|
2023
Q3 | $1.72M | Buy |
51,880
+2,580
| +5% | +$85.6K | 1.05% | 43 |
|
|
2023
Q2 | $1.81M | Buy |
+49,300
| New | +$1.81M | 1.13% | 37 |
|